Hsbc Holdings PLC Roivant Sciences Ltd. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$3.36 - $7.99 $41,522 - $98,740	-12,358 Reduced 51.08%	11,834 $94,000
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $4,169 - $39,567	-8,175 Reduced 25.26%	24,192 $79,000
Q2 2022 Aug 11, 2022	BUY	$2.81 - $4.84 $49,689 - $85,585	17,683 Added 120.42%	32,367 $137,000
Q1 2022 May 16, 2022	BUY	$4.74 - $9.91 $14,115 - $29,511	2,978 Added 25.44%	14,684 $71,000
Q4 2021 Feb 11, 2022	BUY	$5.86 - $13.52 $68,597 - $158,265	11,706 New	11,706 $117,000

314

495M

1.29M

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.28B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.